skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Malcolm

Washington DC, {6D506EDE-F0E4-4964-93FF-D8A3DA23BDA0}

+13 year(s) experience

Malcom Spicer
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets for more than a decade and currently is Senior Editor at Informa Pharma Intelligence’s HBW Insights. He provides authoritative and highly analytical insight into how and why the US Food and Drug Administration regulates OTC drug, including homeopathics, and nutritional supplement manufacturing and marketing and also how companies competing in these industries can most efficiently and effectively comply with FDA regulations, the cornerstone for their success.
Previously, Malcolm covered these industries for the Tan Sheet (now part of HBW Insight), joining the Tan Sheet as Managing Editor in August 2006. He has continued to lead coverage of consumer health products as the consumer sector content has evolved at Informa and he collaborates on coverage strategy with editors at Pink Sheet and other publications. Malcolm also has had experience in covering US health care policy and the global telecommunications industry as well as reporting on topics from litigation to lifestyles, and from crime to commerce for daily newspapers.


Analyst Articles

Articles by Malcolm

  • HBW Insight

    Long-term E-cigarette Use Could Spark More Smoking, French Study Suggests

    By Malcolm Spicer 29 Jul 2019

    Research in JAMA Internal Medicine studied "longitudinal associations between [e-cigarette] use and tobacco smoking patterns in a large population-based cohort study" and found use was associated with reduction in smoking and an increased probability of smoking cessation. But the researchers saw that e-cigarette users who quit tobacco "tended to relapse to smoking more frequently than" former smokers who didn't use e-cigarettes.

    Topic Medtech

  • HBW Insight

    Congress Should Open CBD Door Close VMS Market Holes Sharfstein Cohen

    By Malcolm Spicer 04 Jul 2019

    "We seem to be headed toward a confusing, uneven, and potentially risky market in CBD products. This situation creates an opportunity for Congress to take action," say Joshua Sharfstein and Pieter Cohen in NEJM. Additionally, GW Pharma exec says FDA should reign in the "unfettered" production and sales of food and supplements containing CBD , hemp or other cannabis-based ingredients to prevent potential harm to consumers.

    Topic FDA Policy and regulation

  • HBW Insight

    With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

    By Malcolm Spicer 03 Jul 2019

    Scott Gottlieb claimed higher profile than most previous FDA commissioners with frequent Twitter posts and by including his remarks in many agency communications to industries and consumers. In his nearly two years in post, he also had more central role in FDA initiatives in areas such as keeping unsafe products labeled as supplements off the market and explaining why hemp and CBD are available and supplements even though FDA considers the products noncompliant as dietary ingredients.

    Topic FDA

  • HBW Insight

    FDA Consumer Health Market Oversight Stays In Spotlight In Gottlieb's Final Week

    By Malcolm Spicer 11 Jun 2019

    In four days before Scott Gottlieb's stint as commissioner ended, FDA announced official start of initiative to consider regulatory pathways to make CBD compliant as a dietary ingredient, launched another shot across kratom sector's bow and noted more examples of e-cigarette marketers crossing regulatory lines.

    Topic FDA